Zhitong Finance App News, China Resources Pharmaceutical (03320.HK) announced China Resources 39's 2026 interim results, with total operating revenue of about 15.014 billion yuan, up 1.37% year on year; net profit attributable to shareholders of listed companies was about 1,671 billion yuan, a year-on-year decrease of 7.96%; basic profit per share was 1 yuan, with a cash dividend of 4.15 yuan per 10 shares (tax included)

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.